ClassID:

92576

C07C217/34 - CPC Classification

Classification description:

Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms

Recent Application in this class:
#1
20260008759
2026-01-08

METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF

#2
20220153685
2022-05-19

Small molecule AMPK activators

#3
20220024885
2022-01-27

METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF

#4
20200062693
2020-02-27

Small molecule AMPK activators

#5
20190300492
2019-10-03

METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF

#6
20180265482
2018-09-20

Methods for producing viloxazine salts and novel polymorphs thereof

#7
20180215863
2018-08-02

Amine for low-emission epoxy resin compositions

#8
20160304475
2016-10-20

Methods for producing viloxazine salts and novel polymorphs thereof

#9
20160214973
2016-07-28

Store overload-induced calcium release inhibitors and methods for producing and using the same

#10
20150183723
2015-07-02

Calcilytic compounds

#11
20150126735
2015-05-07

Viloxazine compositions

#12
20140057980
2014-02-27

Calcilytic compounds

#13
20110251198
2011-10-13

Methods for producing viloxazine salts and novel polymorphs thereof

#14
20110171279
2011-07-14

POLYETHYLENIMINE BIOCIDES

#15
20110054021
2011-03-03

Calcilytic compounds

#16
20100311975
2010-12-09

CATIONIC TRANSITION METAL CATALYSTS

#17
20090270367
2009-10-29

Substituted hydroxyethylamine aspartyl protease inhibitors

#18
20090198080
2009-08-06

METHOD FOR THE PREPARATION OF ARYL ETHERS

#19
20090182057
2009-07-16

DEUTERATED AMINOGLYCIDAL COMPOUNDS

#20
20090163589
2009-06-25

Calcilytic compounds

#21
20090023791
2009-01-22

PH-dependent NMDA receptor antagonists

#22
20080015258
2008-01-17

L-(−)-moprolol L-(+)-tartrate

#23
20060183918
2006-08-17

β2-adrenergic receptor agonists

#24
20060128957
2006-06-15

Fluorous tagging and scavenging reactants and methods of synthesis and use thereof

#25
20060094903
2006-05-04

RS 1-{4-[2-(allyloxy)-ethyl]phenoxy}-3-isopropylamino propan-2-ol, process for preparation thereof and process for preparation of RS betaxolol

#26
20060058391
2006-03-16

Calcilytic compounds

#27
20060052315
2006-03-09

Cb 1/cb 2 receptor ligands and their use in the treatment of pain

#28
20060025474
2006-02-02

Bisphenyl compounds useful as vitamin D3 receptor agonists

#29
20060014779
2006-01-19

3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake

#30
20060004109
2006-01-05

Process for preparation of S-(-)-betaxolol and salts thereof

#31
20050261318
2005-11-24

Protein kinase inhibitors

#32
20050239836
2005-10-27

Substituted hydroxyethylamine aspartyl protease inhibitors

#33
20050209275
2005-09-22

β2-adrenergic receptor agonists

#34
20050187399
2005-08-25

Method for the preparation of aryl ethers